ArticleJournal of the Egyptian National Cancer Institute2021

Medulloblastoma: clinicopathological parameters, risk stratification, and survival analysis of immunohistochemically validated molecular subgroups.

Asmaa Mustafa Eid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.